The results indicated that Runyan Mixture may play a role in the treatment of pharyngitis mainly by acting on core targets, such as EGFR, MAPK1, AKT1, PIK3CA, NFKB1, SRC, TNF, MAPK8, MET, and PTGS2. The gene discussed is MAPK1; the disease is pharyngitis.